Bicycle Therapeutics BCYC
NASDAQ BCYC
$4.30 +0.06 (+1.42%)
At close: Sep 4, 2026 · 4:00 PM EDT

Bicycle Therapeutics (BCYC) Other financing activities (2018 - 2026)

Bicycle Therapeutics' (BCYC) quarterly Other financing activities came in at $1000.0 in Q2 2026, little changed YoY from $1000.0 in Q2 2025, and down 91.67% on a QoQ basis from $12000.0 in Q1 2026.

Analysis

Bicycle Therapeutics (BCYC) Other financing activities (2018 - 2026) Analysis & Trends

Bicycle Therapeutics (BCYC) has 9 years of Other financing activities data on file, last reported at $1000.0 in Q2 2026.

  • Quarterly Other financing activities changed 0.0% year-over-year to $1000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $47000.0 (down 95.95% YoY) and the FY2025 annual result came in at $37000.0, down 99.51% from the prior year.
  • Other financing activities slipped to $1000.0 in Q2 2026, from $12000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $4.5 million in Q2 2024 to a low of $1000.0 in Q2 2025.
  • A 5-year average of $513833.3 and a median of $162000.0 in 2022 frame the typical range for Other financing activities.
  • Annual changes were most pronounced in 2024 — Other financing activities jumped 93450.0% — and 2025, when it plunged 99.98%.
  • Tracing BCYC's Other financing activities over 5 years: stood at $185000.0 in 2022, then surged by 103.24% to $376000.0 in 2023, then slumped by 34.84% to $245000.0 in 2024, then sank by 86.53% to $33000.0 in 2025, then sank by 96.97% to $1000.0 in 2026.
  • The last three Other financing activities figures came in at $1000.0 (Q2 2026), $12000.0 (Q1 2026), and $33000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Bicycle Therapeutics 299.81 Mn 299.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,000.00
Mar 31, 2026 12,000.00
Dec 31, 2025 33,000.00
Sep 30, 2025 1,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 2,000.00
Dec 31, 2024 245,000.00
Sep 30, 2024 912,000.00
Jun 30, 2024 4.50 Mn
Mar 31, 2024 1.87 Mn
Dec 31, 2023 376,000.00
Sep 30, 2023 139,000.00
Jun 30, 2023 165,000.00
Mar 31, 2023 2,000.00
Dec 31, 2022 185,000.00
Sep 30, 2022 159,000.00
Jun 30, 2022 195,000.00
Mar 31, 2022 450,000.00
Dec 31, 2021 2.28 Mn
Sep 30, 2021 3.05 Mn